Gene Therapy, RNA-Focused Biotechs Lead China December Fundraising

funding
Gene therapies and RNA technology remained in the limelight in China's December VC/PE deals. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from China

More from Focus On Asia